Royalty Pharma plc - Ordinary Shares - Class A

NASDAQ:RPRX  
43.85
-0.19 (-0.43%)
6:51:59 PM EDT: $44.50 +0.65 (+1.48%)
Earnings Announcements

Royalty Pharma Reports Third Quarter 2022 Results

Published: 11/08/2022 12:49 GMT
Royalty Pharma plc - Ordinary Shares - Class A (RPRX) - Royalty Pharma Reports Third Quarter 2022 Results.
Royalty Pharma - Qtrly Total Income and Other Revenues Decreased 2% to $573 Million.
Royalty Pharma - Raising Financial Guidance for 2022.
Revenue is expected to be $967.23 Million
Adjusted EPS is expected to be $1.36

Next Quarter Revenue Guidance is expected to be $615.4 Million
Next Quarter EPS Guidance is expected to be $0.77

More details on our Analysts Page.